Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Blood and Lymphatic Cancer : Targets and Therapy|November 7, 2019
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimensFangwen Zhang, Ling Li, Lei Zhang, et al.
Peerj|August 24, 2022
A cholesterogenic gene signature for predicting the prognosis of young breast cancer patientsXiaoping Li, Chaorong Zhou, Chaoran Qiu, et al.
DNA and Cell Biology|December 1, 2022
ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon CancerXianqiu Wu, Bin Wang, Yaorong Su, et al.
International Journal of Biological Sciences|January 9, 2025
The positive feedback loop between SP1 and MAP2K2 significantly drives resistance to VEGFR inhibitors in clear cell renal cell carcinomaZhinan Xia, Zitong Yang, Yu Dong, et al.
Scientific Reports|June 5, 2025
Correlation between ADGRV1 expression and clinical pathological and prognostic features in breast cancerLili Wang, Jiadi He, Jiaqing Chen, et al.
Proteomics|July 5, 2014
SILAC-based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cellsHongyu Zhang, Peng Wu, Fangyan Chen, et al.
Molecular Therapy Oncolytics|September 13, 2021
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signalingAibin Liu, Huayan Xie, Ronggang Li, et al.
International Journal of Cancer|August 29, 2018
Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancerLiping Ye, Fengyan Li, Yipeng Song, et al.
Journal of Zhejiang University. Science. B|January 6, 2026
Constructing a PANoptosis-based prognostic signature to evaluate the immune landscape and therapeutic response in clear cell renal cell carcinomaYu Dong, Zitong Yang, Zhinan Xia, et al.
Oncogene|April 3, 2019
AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathwayYanmei Cui, Xianqiu Wu, Chuyong Lin, et al.
Pageof 6